Erratum: Characterization of the interactive effects of glycine and D-cycloserine in men: Further evidence for enhanced NMDA receptor function associated with human alcohol dependence (Neuropsychopharmacology (2011) 36 (701-710) DOI: 10.1038/npp.2010.203);Characterization of the interactive effects of glycine and D-cycloserine in men: Further evidence for enhanced NMDA receptor function associated with human alcohol dependence

Neuropsychopharmacology

Volumn 36, Issue 3, 2011, Pages 701-710

  Krystal, John H ^a,b,c   Petrakis, Ismene L ^a,b,c   Limoncelli, Diana ^a,b,c   Nappi, Susan Krasnicki ^b   Trevisan, Louis ^a,b,c   Pittman, Brian ^a,b,c   D'Souza, Deepak C ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Yale University School of Medicine   (United States)

Author keywords

alcohol dependence; D cycloserine; ethanol; glycine; learning and memory; NMDA receptor

Indexed keywords

ALCOHOL; CYCLOSERINE; GLYCINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO; SERINE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ALERTNESS; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISTRACTIBILITY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERANCE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECALL; WORKING MEMORY;

EID: 78651398231     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2011.2     Document Type: Erratum

References (53)

1. Allgaier C, Scheibler P, Muller D, Feuerstein TJ, Illes P (1999). NMDA receptor characterization and subunit expression in rat cultured mesencephalic neurones. Br J Pharmacol 126: 121-130. (Pubitemid 29041751)
2. Barnett JH, Salmond CH, Jones PB, Sahakian BJ (2006). Cognitive reserve in neuropsychiatry. Psychol Med 36: 1053-1064.
3. Barr LC, D'Souza DC, Price LH, Krystal JH (1994). Evaluation of dose-related effects of D-cycloserine in unmedicated obsessive compulsive disorder patients. Soc Neurosci Abstr 20: 1564 (abstract no. 641.9).
4. Bienkowski P, Krzascik P, Koros E, Kostowski W, Scinska A, Danysz W (2001). Effects of a novel uncompetitive NMDA receptor antagonist, MRZ 2/579 on ethanol self-administration and ethanol withdrawal seizures in the rat. Eur J Pharmacol 413: 81-89.
5. Bienkowski P, Stefanski R, Kostowski W (1997). Discriminative stimulus effects of ethanol: lack of antagonism with N-methyl-D-aspartate and D-cycloserine. Alcohol 14: 345-350. (Pubitemid 27271061)
6. Bisaga A, Evans SM (2004). Acute effects of memantine in combination with alcohol in moderate drinkers. Psychopharma-cology 172: 16-24.
7. Brandt J (1991). The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychologist 5: 125-142.
8. Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS et al (1998). Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress 11: 125-136.
9. Brunner E, Domhof S, Langer F (2002). Nonparametric Analysis of Longitudinal Data in Factorial Experiments. Wiley: Hoboken, NJ.
10. D'Souza DC, Gil R, Cassello K, Morrissey K, Abi-Saab D, White J et al (2000). IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans. Biol Psychiatry 47: 450-462.
11. Danysz W, Parsons CG (1988). Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50: 597-664.
12. Darstein MB, Landwehrmeyer GB, Feuerstein TJ (2000). Changes in NMDA receptor subunit gene expression in the rat brain following withdrawal from forced long-term ethanol intake. Naunyn Schmiedebergs Arch Pharmacol 361: 206-213.
13. David V, Ionescu M, Dumitrescu V (2001). Determination of cycloserine in human plasma by high-performance liquid chromatography with fluorescence detection, using derivatiza-tion with p-benzoquinone. J Chromatogr B 761: 27-33.
14. Dickerson D, Pittman B, Ralevski E, Perrino A, Limoncelli D, Edgecombe J et al (2010). Ethanol-like effects of thiopental and ketamine in healthy humans. J Psychopharmacol 24: 203-211.
15. Emmett MR, Mick SJ, Cler JA, Rao TS, Iyengar S, Wood PL (1991). Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo. Neuropharmacology 30: 1167-1171.
16. Evans SM, Levin FR, Brooks DJ, Garawi F (2007). A pilot double-blind treatment trial of memantine for alcohol dependence. Alcohol Clin Exp Res 31: 775-782.
17. Fein G, McGillivray S (2007). Cognitive performance in long-term abstinent elderly alcoholics. Alcohol Clin Exp Res 31: 1788-1799.
18. Gonzales RA, Brown LM (1995). Brain regional differences in glycine reversal of ethanol-induced inhibition of N-methyl-D-aspartate-stimulated neurotransmitter release. Life Sci 56: 571-577.
19. Gordon M (1983). Gordon Diagnostic Systems. Gordon Systems: DeWitt, NY.
20. Grant KA, Lovinger DM (1995). Cellular and behavioral neuro-biology of alcohol: receptor-mediated neuronal processes. Clin Neurosci 3: 155-164.
21. Hariharan M, Naga S, VanNoord T (1993). Systematic approach to the development of plasma amino acid analysis by high-performance liquid chromatography with ultraviolet detection with precolumn derivatization using phenyl isothiocyanate. J Chromatogr 621: 15-22.
22. Hoffman PL (2003). NMDA receptors in alcoholism. Int Rev Neurobiol 56: 35-82.
23. Hoffman PL, Grant KA, Snell LD, Reinlib L, Iorio K, Tabakoff B (1992). NMDA receptors: role in ethanol withdrawal seizures. Ann N Y Acad Sci 654: 52-60.
24. Hood WF, Compton RP, Monahan JB (1989). -Cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett 98: 91-95.
25. Koller G, Zill P, Fehr C, Pogarell O, Bondy B, Soyka M et al (2009). No association of alcohol dependence with SLC6A5 and SLC6A9 glycine transporter polymorphisms. Addict Biol 14: 506-508.
26. Kostowski W, Bienkowski P (1999). Discriminative stimulus effects of ethanol: neuropharmacological characterization. Alcohol 17: 63-80. (Pubitemid 29225855)
27. Kotlinska J, Liljequist S (1997). The NMDA/glycine receptor antagonist, L-701,324, produces discriminative stimuli similar to those of ethanol. Eur J Pharmacol 332: 1-8.
28. Krueger JM, O'Connor AJ, Kelso SR (1997). Glycine site agonists exhibit subunit specific effects on NMDA receptors expressed in Xenopus oocytes. Soc Neurosci Abstr 23: 945.
29. Krupitsky EM, Neznanova O, Masalov D, Burakov AM, Didenko T, Romanova T et al (2007a). Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients. Am J Psychiatry 164: 519-523.
30. Krupitsky EM, Rudenko AA, Burakov AM, Slavina TY, Grinenko AA, Pittman B et al (2007b). Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam. Alcohol Clin Exp Res 31: 604-611.
31. Krystal J, Petrakis I, Krasnicki S, Trevisan L, Boutros N, D'Souza DC (1998a). Altered responses to agonists of the strychnine-insensitive glycine NMDA coagonist (SIGLY) site in recently detoxified alcoholics. Alcohol Clin Exp Res 22: 94A.
32. Krystal JH, Petrakis IL, Limoncelli D, Webb E, Gueorgueva R, D'Souza DC et al (2003a). Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients. Neuropsychopharmacology 28: 2020-2028.
33. Krystal JH, Petrakis IL, Mason G, D'Souza DC (2003b). NMDA glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Therap 99: 79-94.
34. Krystal JH, Petrakis IL, Trevisan L, D'Souza DC (2003c). NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Ann N Y Acad Sci 1003: 176-184.
35. Krystal JH, Petrakis IL, Webb E, Cooney NL, Karper LP, Namanworth S et al (1998b). Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry 55: 354-360.
36. Krystal JH, Petrakis IL, Webb E, Cooney NL, Karper LP, Namanworth S et al (1998c). Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry 55: 354-360.
37. Krystal JH, Webb E, Cooney N, Kranzler HR, Charney DS (1994). Specificity of ethanol like effects elicited by serotonergic and noradrenergic mechanisms. Archiv Gen Psychiatry 51: 898-911.
38. Kumari M, Ticku MK (2000). Regulation of NMDA receptors by ethanol. Progr Drug Res 54: 151-189.
39. Lido HH, Stomberg R, Fagerberg A, Ericson M, Soderpalm B (2009). The glycine reuptake inhibitor org 25935 interacts with basal and ethanol-induced dopamine release in rat nucleus accumbens. Alcohol Clin Exp Res 33: 1151-1157.
40. Martin CS, Earleywine M, Musty RE, Perrine MW, Swift RM (1993). Development and validation of the Biphasic Alcohol Effects Scale. Alcohol Clin Exp Res 17: 140-146.
41. Molander A, Lido HH, Lof E, Ericson M, Soderpalm B (2007). The glycine reuptake inhibitor Org 25935 decreases ethanol intake and preference in male wistar rats. Alcohol Alcohol 42: 11-18.
42. Morgan CJ, Perry EB, Cho HS, Krystal JH, D'Souza DC (2006). Greater vulnerability to the amnestic effects of ketamine in males. Psychopharmacology (Berl) 187: 405-414.
43. Petrakis IL, Limoncelli D, Gueorguieva R, Jatlow P, Boutros NN, Trevisan L et al (2004). Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry 161: 1776-1782.
44. Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E et al (2001). The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Neuropharmacology 40: 749-760.
45. Schutz CG, Soyka M (2000). Dextromethorphan challenge in alcohol-dependent patients and controls. Arch Gen Psychiatry 57: 291-292.
46. Sheinin A, Shavit S, Benveniste M (2001). Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine. Neuropharmacology 41: 151-158.
47. Spitzer RL, Williams JB, Gibbon M, First MB (1992). The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49: 624-629.
48. Spitzer RL, Williams JBW, Gibbon M, First MB (1990). Structured Clinical Interview for DSM-III-R-Nan-Patient Edition (SCID-NP, Version 1.0 with supplement for DSM-IV). American Psychiatric Press: Washington, D.C.
49. Stern RA, Silva SG, Chaisson N, Evans DL (1996). Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Arch Neurol 53: 148-153.
50. Trevisan L, Petrakis IL, Pittman B, Gueorguieva R, D'Souza DC, Perry E et al (2008). Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine(B) site of NMDA glutamate receptors. Alcohol Clin Exp Res 32: 36-42.
51. von Knorring AL, Bohman M, von Knorring L, Oreland L (1985). Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psychiatr Scand 72: 51-58.
52. Watson GB, Bolanowski MA, Baganoff MP, Deppeler CL, Lanthorn TH (1990). -Cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes. Brain Res 510: 158-160.
53. Witkin JM, Brave S, French D, Geter-Douglass B (1995). Discriminative stimulus effects of R-(+)-3-amino-1-hydroxy-pyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor. J Pharmacol Exp Ther 275: 1267-1273.